GALEOTTI, NICOLETTA
 Distribuzione geografica
Continente #
EU - Europa 25.135
NA - Nord America 20.410
AS - Asia 8.651
SA - Sud America 1.331
AF - Africa 273
OC - Oceania 194
Continente sconosciuto - Info sul continente non disponibili 7
Totale 56.001
Nazione #
US - Stati Uniti d'America 20.194
PL - Polonia 15.972
RU - Federazione Russa 3.447
SG - Singapore 2.352
CN - Cina 1.954
IT - Italia 1.288
HK - Hong Kong 1.222
VN - Vietnam 1.098
BR - Brasile 1.082
IE - Irlanda 950
SE - Svezia 827
KR - Corea 783
DE - Germania 559
UA - Ucraina 471
FI - Finlandia 465
FR - Francia 417
GB - Regno Unito 361
IN - India 289
ID - Indonesia 198
AU - Australia 185
JP - Giappone 142
CA - Canada 128
NL - Olanda 112
TR - Turchia 111
BD - Bangladesh 94
AR - Argentina 93
JO - Giordania 78
CI - Costa d'Avorio 56
IQ - Iraq 56
MX - Messico 53
ES - Italia 43
RO - Romania 39
CH - Svizzera 37
PK - Pakistan 37
EC - Ecuador 35
NG - Nigeria 35
ZA - Sudafrica 35
PT - Portogallo 32
SC - Seychelles 32
CO - Colombia 28
TW - Taiwan 28
BE - Belgio 25
EG - Egitto 24
MA - Marocco 22
PE - Perù 22
PY - Paraguay 22
AZ - Azerbaigian 20
VE - Venezuela 20
PH - Filippine 19
SA - Arabia Saudita 19
CL - Cile 18
TH - Thailandia 18
UZ - Uzbekistan 18
AT - Austria 15
IL - Israele 15
KE - Kenya 15
NP - Nepal 15
BJ - Benin 12
TN - Tunisia 12
IR - Iran 11
LT - Lituania 11
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
NZ - Nuova Zelanda 9
AL - Albania 8
BH - Bahrain 8
KG - Kirghizistan 8
BG - Bulgaria 7
JM - Giamaica 7
LB - Libano 7
OM - Oman 7
BO - Bolivia 6
KZ - Kazakistan 6
SY - Repubblica araba siriana 6
AM - Armenia 5
AO - Angola 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
GR - Grecia 5
LV - Lettonia 5
MD - Moldavia 5
MY - Malesia 5
RS - Serbia 5
UY - Uruguay 5
CR - Costa Rica 4
ET - Etiopia 4
HN - Honduras 4
HU - Ungheria 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
DK - Danimarca 3
EU - Europa 3
GT - Guatemala 3
PA - Panama 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
GE - Georgia 2
IS - Islanda 2
KW - Kuwait 2
Totale 55.975
Città #
Warsaw 15.954
Santa Clara 3.935
Ashburn 2.441
Singapore 1.716
Fairfield 1.680
Hong Kong 1.010
Dublin 940
Chandler 791
Woodbridge 786
Seattle 735
Cambridge 697
Jacksonville 686
Seoul 664
Houston 619
Wilmington 600
San Jose 554
Council Bluffs 458
Hefei 432
Beijing 395
Altamura 316
Lawrence 281
Dong Ket 279
Ann Arbor 266
Los Angeles 247
Princeton 246
Ho Chi Minh City 243
The Dalles 243
Lauterbourg 217
Buffalo 207
Helsinki 205
Hanoi 191
Boardman 189
Dallas 180
Boston 173
Jakarta 166
San Diego 160
Melbourne 149
Moscow 141
Mumbai 141
Florence 130
Paris 129
Tokyo 123
Phoenix 122
Milan 104
Medford 103
New York 97
Shanghai 93
Munich 91
São Paulo 85
Falls Church 80
Seongnam 73
Izmir 68
Kent 64
Abidjan 56
Redondo Beach 45
Frankfurt am Main 44
London 42
Washington 41
Norwalk 40
Orem 39
Turku 37
Chicago 36
Guangzhou 36
Rome 35
Timisoara 33
Amsterdam 31
Brooklyn 31
Hillsboro 31
Montreal 31
Abuja 30
Auburn Hills 29
Belo Horizonte 29
Verona 29
Dearborn 28
Clifton 27
Bern 26
Da Nang 26
Tianjin 26
Toronto 26
Atlanta 25
Frankfurt Am Main 25
Haiphong 25
Rio de Janeiro 25
Andover 24
Bengaluru 24
Brussels 24
Chennai 24
Denver 23
San Francisco 22
West Jordan 22
Groningen 21
Lappeenranta 21
Baghdad 20
Baku 19
Zhengzhou 19
Yubileyny 18
Hangzhou 17
Naples 17
Nuremberg 17
Vancouver 17
Totale 42.028
Nome #
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 629
M1 receptor activation is a requirement for arecoline analgesia. 610
LOCAL ANAESTHETIC AVTIVITY OF ESSENTIAL OIL OF LAVANDULA ANGUSTIFOLIA 522
Antinociceptive property of the nicotinic agonist AG4 in rodents 518
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 429
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 408
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 407
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 403
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 401
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 389
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 388
Ryanodine receptors are involved in muscarinic antinociception in mice. 388
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 384
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 368
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 367
4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels. 366
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 358
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 355
Neurotransmitter role of endogenous morphine in CNS. 355
The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model. 355
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 355
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 353
Brain histamine is crucial for selective serotonin reuptake inhibitors behavioral and neurochemical effects 347
ERK1/2 phosphorylation is involved in the antidepressant-like action of 2,5-diphenyl-3-(4-fluorophenylseleno)-selenophene in mice 339
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 336
Local anaesthetic activity of beta-caryophyllene. 335
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 331
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 331
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 331
Antihyperalgesic activity of verbascoside in the chronic constriction injury of the sciatic nerve (CCI) and intra-articular injection of sodium monoiodoacetate (MIA) models of neuropatic pain 331
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 330
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 328
Antihyperalgesic activity of verbascoside in two models of neuropathic pain. 328
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 326
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 325
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 323
IS BRAIN HISTAMINE INVOLVED IN DEPRESSION? 320
LOCAL ANAESTHETIC ACTIVITY OF MONOTERPENES AND PHENYLPROPANES OF ESSENTIAL OILS 318
Antisense knockdown of the Shaker Kv1.1 gene family abolishes the central stimulatory effect of amphetamines in mice and rats. 318
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 318
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 316
Central neuronal functions of histamine H4 receptors 316
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 314
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 314
Methylamine: a new endogenous modulator of neuron firing? 314
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 313
Role of intracellular calcium in acute thermal pain perception 312
Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation. 312
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 311
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 311
Effect of K+ channel modulation on mouse feeding behaviour 308
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition-enhancers 307
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 307
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 307
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 304
Prochlorperazine induces central antinociception mediated by the muscarinic system. 304
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 304
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 302
Contribution of G inhibitory protein alpha subunits in paradoxical hyperalgesia elicited by exceedingly low doses of morphine in mice. 302
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 301
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 299
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 299
THE ANOREXIANT EFFECT OF OLEOYLETHANOLAMIDE IS MODULATED BY NEURONAL HISTAMINE 299
Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels 298
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 297
THE CENTRAL CHOLINERGIC SYSTEM HAS A ROLE IN THE ANTINOCICEPTION INDUCED IN RODENTS AND GUINEA-PIGS BY THE ANTIMIGRAINE DRUG SUMATRIPTAN 296
Pharmacological in vivo test to evaluate the bioavailability of some St. John's wort innovative oral preparations 295
Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain. 295
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 294
Memory facilitation with atropine: a paradoxical effect 294
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 293
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 293
Signaling pathway of morphine induced acute thermal hyperalgesia in mice. 293
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 293
Antidepressant phenotype by inhibiting the phospholipase Cβ(1)--protein kinase Cγ pathway in the forced swim test. 293
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 292
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 292
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 292
Influence of potassium channel modulators on cognitive processes in mice 290
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 288
ROLE OF 5-HT4 RECEPTORS IN THE MOUSE PASSIVE AVOIDANCE TEST 287
Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice. 287
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 287
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 286
Pharmacological in vivo test to evaluate the bioavailability of some St. John’s wort innovative oral preparations 286
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channe 285
Caffeine induces central cholinergic analgesia. 284
Lavender (Lavandula angustifolia Mill.) Essential Oil Alleviates Neuropathic Pain in Mice With Spared Nerve Injury 284
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 284
Endogenous morphine modulates acute thermonociception in mice. 284
ANTINOCICEPTIVE EFFECT OF R-(+)-HYOSCYAMMINE ON THE CONJUNCTIVAL REFLEX TEST IN RABBITS 282
In vitro characterization of a novel, potent and selective M3 antagonist 281
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 279
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 278
INDOMETHACIN, CAFFEINE AND PROCHLORPERAZINE ALONE AND COMBINED REVERT HYPERALGESIA IN VIVO MODELS OF MIGRAINE 278
St. John's wort relieves pain in an animal model of migraine. 277
Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. 277
Pleiotropic effect of histamine H4 receptor modulation in the central nervous system 276
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 276
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. 270
Totale 32.715
Categoria #
all - tutte 128.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 0 0 0 0 0 0 0 0 0 131 471
2021/20221.848 48 176 180 58 87 99 74 130 98 129 330 439
2022/20234.004 392 785 187 244 334 717 528 227 369 18 141 62
2023/20242.032 85 190 322 109 135 250 71 537 48 113 91 81
2024/202511.216 349 1.018 664 1.432 3.421 1.577 225 600 570 378 570 412
2025/202612.430 1.280 1.763 1.191 905 1.338 633 1.600 806 990 1.050 874 0
Totale 56.363